awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33573055-BC53486A-F6D1-4AA7-9D19-B308AA1AA53F
Q33573055-BC53486A-F6D1-4AA7-9D19-B308AA1AA53F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33573055-BC53486A-F6D1-4AA7-9D19-B308AA1AA53F
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
P2860
Q33573055-BC53486A-F6D1-4AA7-9D19-B308AA1AA53F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33573055-BC53486A-F6D1-4AA7-9D19-B308AA1AA53F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
231bcea39177074ffa1a33da69782a0832b2f380
P2860
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.